Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sight Sciences (SGHT) Payables (2020 - 2026)

Sight Sciences has reported Payables over the past 6 years, most recently at $3.6 million for Q4 2025.

  • For Q4 2025, Payables fell 11.89% year-over-year to $3.6 million; the TTM value through Dec 2025 reached $3.6 million, down 11.89%, while the annual FY2025 figure was $3.6 million, 11.89% down from the prior year.
  • Payables for Q4 2025 was $3.6 million at Sight Sciences, down from $3.9 million in the prior quarter.
  • Over five years, Payables peaked at $6.2 million in Q3 2022 and troughed at $1.7 million in Q4 2023.
  • A 5-year average of $3.9 million and a median of $3.9 million in 2025 define the central range for Payables.
  • Biggest five-year swings in Payables: skyrocketed 234.64% in 2022 and later tumbled 65.23% in 2025.
  • Year by year, Payables stood at $4.2 million in 2021, then tumbled by 35.48% to $2.7 million in 2022, then plummeted by 35.6% to $1.7 million in 2023, then skyrocketed by 136.68% to $4.1 million in 2024, then fell by 11.89% to $3.6 million in 2025.
  • Business Quant data shows Payables for SGHT at $3.6 million in Q4 2025, $3.9 million in Q3 2025, and $2.1 million in Q2 2025.